Glenmark Pharma inks exclusive licensing agreement with Lotus International

Glenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3GNltp1
via IFTTT